Cure Pharmaceutical Holding Corp.

EDGAR

63 filing records in this dataset, filed from 2015-06-10 to 2024-11-19. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

See all insider transactions

Latest quarter

Revenue

192 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Operating margin

-261.98%

2024 Q3 · %

Exact inputs and evidence
  • Operating Income: -503000 USD Source
  • Revenue: 192000 USD Source

Operating cash flow

-89 thousand USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -1021000 USD Source
  • Operating Cash Flow: -932000 USD Source
Cash and cash equivalents
11 thousand USD Source
Exact value

11000 USD

Long-term debt including current maturities
Not available
Shares outstanding
78.9 million shares Source
Exact value

78925168 shares

Reported share-count change

7.83% · 5.73 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 73195429 shares · 2023-09-30· Source
  • 78925168 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-2.76 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Net income: -3444000 USD · 2023-01-01 – 2023-12-31 Source
  • Net income: -3420000 USD · 2023-01-01 – 2023-09-30 Source
  • Net income: -1295000 USD · 2024-01-01 – 2024-03-31 Source
  • Net income: -897000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -541000 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-1.55 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Operating cash flow: -3843000 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -3319000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -618000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -932000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -618000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -1021000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -932000 USD · 2024-01-01 – 2024-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-19.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 10 of 11 periods available· newest 2023-12-31
  • Operating income: 10 of 11 periods available· newest 2023-12-31
  • Net income: 10 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 10 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 7 of 11 periods available· newest 2023-12-31
  • Total assets: 10 of 11 periods available· newest 2023-12-31
  • Total liabilities: 10 of 11 periods available· newest 2023-12-31
  • Current assets: 10 of 11 periods available· newest 2023-12-31
  • Current liabilities: 10 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 9 of 11 periods available· newest 2023-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 10 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -11.2%

    Prior period

    USD 4.9 million

    –

    Current period

    USD 4.35 million

    –

    Exact inputs and evidence

    4347000 − 4896000 = -549000 USD

    4896000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    4347000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 22.07 million

    Prior period

    −USD 25.51 million

    –

    Current period

    −USD 3.44 million

    –

    Exact inputs and evidence

    -3444000 − -25509000 = 22065000 USD

    -25509000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -3444000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 6.23 million

    Prior period

    −USD 10.07 million

    –

    Current period

    −USD 3.84 million

    –

    Exact inputs and evidence

    -3843000 − -10073000 = 6230000 USD

    -10073000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -3843000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +100%

    Prior period

    USD 1,000

    –

    Current period

    USD 2,000

    –

    Exact inputs and evidence

    2000 − 1000 = 1000 USD

    1000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    2000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 4.35 million 100% of revenue
  • Cost of revenue USD 1.24 million 28% of revenue
  • Operating expenses USD 8.62 million 198% of revenue
  • Operating income −USD 5.51 million −127% of revenue
  • Tax, interest and other Derived −USD 2.06 million −47% of revenue
  • Net income −USD 3.44 million −79% of revenue

Cash

  • Operating cash flow −USD 3.84 million −88% of revenue
  • Capital expenditure USD 2,000 0% of revenue
  • Free cash flow Derived −USD 3.85 million −88% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2015 Operating loss: operating costs were 937% of revenue.
  • 2016 Operating loss: operating costs were 192% of revenue.
  • 2016 Operating loss: operating costs were 4,765% of revenue.
  • 2017 Operating loss: operating costs were 4,170% of revenue.
  • 2018 Operating loss: operating costs were 1,394% of revenue.
  • 2019 Operating loss: operating costs were 2,298% of revenue.
  • 2020 Operating loss: operating costs were 1,024% of revenue.
  • 2021 Operating loss: operating costs were 271% of revenue.
  • 2022 Operating loss: operating costs were 473% of revenue.
  • 2023 Operating loss: operating costs were 227% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2015 2015-01-01 – 2015-12-31183430 1718958 Derived -1535528 67533 Derived -1603061 Unavailable
Source
2016 2015-04-01 – 2016-03-3111395 21852 Derived -10457 0 Derived -10457 Unavailable
Source
2016 2016-01-01 – 2016-12-3184165 4010409 Derived -3926244 231236 Derived -4157480 Unavailable
Source
2017 2017-01-01 – 2017-12-31180404 7522511 Derived -7342107 821588 Derived -8163695 Unavailable
Source
2018 2018-01-01 – 2018-12-31584000 8142000 Derived -7558000 2843000 Derived -10401000 Unavailable
Source
2019 2019-01-01 – 2019-12-31623000 14315000 Derived -13692000 7681000 Derived -21373000 -8510000 Derived
Source
2020 2020-01-01 – 2020-12-312051000 21009000 Derived -18958000 11663000 Derived -30621000 -10395000 Derived
Source
2021 2021-01-01 – 2021-12-316078000 16470000 Derived -10392000 2801000 Derived -13193000 -4315000 Derived
Source
2022 2022-01-01 – 2022-12-314896000 23166000 Derived -18270000 7239000 Derived -25509000 -10074000 Derived
Source
2023 2023-01-01 – 2023-12-314347000 9853000 Derived -5506000 -2062000 Derived -3444000 -3845000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.3M 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.6M4.9M3.3M1.6M0.0201520192023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Revenue183430
2016Revenue11395
2016Revenue84165
2017Revenue180404
2018Revenue584000
2019Revenue623000
2020Revenue2051000
2021Revenue6078000
2022Revenue4896000
2023Revenue4347000

Revenue growth

Change in revenue from the same financial period one year earlier.

-11.2% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.252%170%88%5%-77%201520192023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2015Year over yearNo prior comparable period
2016Year over yearNo prior comparable period
2016Year over year-54.1%
2017Year over year114.3%
2018Year over year223.7%
2019Year over year6.7%
2020Year over year229.2%
2021Year over year196.3%
2022Year over year-19.4%
2023Year over year-11.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -126.7% 2023
Net margin -79.2% 2023
Free cash flow margin -88.5% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.395%-1,037%-2,470%-3,902%-5,335%201520192023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2015Operating margin-837.1%
2016Operating margin-91.8%
2016Operating margin-4,664.9%
2017Operating margin-4,069.8%
2018Operating margin-1,294.2%
2019Operating margin-2,197.8%
2020Operating margin-924.3%
2021Operating margin-171%
2022Operating margin-373.2%
2023Operating margin-126.7%
2015Net margin-873.9%
2016Net margin-91.8%
2016Net margin-4,939.7%
2017Net margin-4,525.2%
2018Net margin-1,781%
2019Net margin-3,430.7%
2020Net margin-1,493%
2021Net margin-217.1%
2022Net margin-521%
2023Net margin-79.2%
2015Free cash flow marginNot reported
2016Free cash flow marginNot reported
2016Free cash flow marginNot reported
2017Free cash flow marginNot reported
2018Free cash flow marginNot reported
2019Free cash flow margin-1,366%
2020Free cash flow margin-506.8%
2021Free cash flow margin-71%
2022Free cash flow margin-205.8%
2023Free cash flow margin-88.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.8M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.817.4K-2.1M-5.0M-8.0M-10.9M201520192023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Operating cash flow-402092
2016Operating cash flow10708
2016Operating cash flow-3516430
2017Operating cash flow-3555668
2018Operating cash flow-4099000
2019Operating cash flow-8102000
2020Operating cash flow-9722000
2021Operating cash flow-4315000
2022Operating cash flow-10073000
2023Operating cash flow-3843000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.8M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.831.6K-2.2M-5.2M-8.2M-11.2M201520192023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Free cash flowUnavailable
2016Free cash flowUnavailable
2016Free cash flowUnavailable
2017Free cash flowUnavailable
2018Free cash flowUnavailable
2019Free cash flow-8510000
2020Free cash flow-10395000
2021Free cash flow-4315000
2022Free cash flow-10074000
2023Free cash flow-3845000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

479.2% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.518%388%259%129%0%201520192023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2015Liabilities / assets310.4%
2016Liabilities / assets28.8%
2016Liabilities / assets39.4%
2017Liabilities / assets194.7%
2018Liabilities / assets251.8%
2019Liabilities / assets58.4%
2020Liabilities / assets54.1%
2021Liabilities / assets60.3%
2022Liabilities / assets203.7%
2023Liabilities / assets479.2%

Current assets to current liabilities

Current assets divided by current liabilities.

0.16× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.75×2.06×1.37×0.69×0.00×201520192023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2015Current assets / current liabilities0.06×
2016Current assets / current liabilities1.77×
2016Current assets / current liabilities2.54×
2017Current assets / current liabilities0.21×
2018Current assets / current liabilities0.19×
2019Current assets / current liabilities0.52×
2020Current assets / current liabilities0.27×
2021Current assets / current liabilities0.07×
2022Current assets / current liabilities0.43×
2023Current assets / current liabilities0.16×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2015 2015-01-01 – 2015-12-31
−USD 1.6 million
Exact value

Exact value: -1603061 USD

2015-01-01 – 2015-12-31: -1603061 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 402,092
Exact value

Exact value: -402092 USD

2015-01-01 – 2015-12-31: -402092 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2016 2015-04-01 – 2016-03-31
−USD 10,457
Exact value

Exact value: -10457 USD

2015-04-01 – 2016-03-31: -10457 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10,708
Exact value

Exact value: 10708 USD

2015-04-01 – 2016-03-31: 10708 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable The mapped spending value is negative, so its direction is unclear.
Source
Unavailable

Capital expenditure has a negative mapped value; spending direction is unclear.

2016 2016-01-01 – 2016-12-31
−USD 4.16 million
Exact value

Exact value: -4157480 USD

2016-01-01 – 2016-12-31: -4157480 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.52 million
Exact value

Exact value: -3516430 USD

2016-01-01 – 2016-12-31: -3516430 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2017 2017-01-01 – 2017-12-31
−USD 8.16 million
Exact value

Exact value: -8163695 USD

2017-01-01 – 2017-12-31: -8163695 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.56 million
Exact value

Exact value: -3555668 USD

2017-01-01 – 2017-12-31: -3555668 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
−USD 10.4 million
Exact value

Exact value: -10401000 USD

2018-01-01 – 2018-12-31: -10401000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.1 million
Exact value

Exact value: -4099000 USD

2018-01-01 – 2018-12-31: -4099000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable The mapped spending value is negative, so its direction is unclear.
Source
Unavailable

Capital expenditure has a negative mapped value; spending direction is unclear.

2019 2019-01-01 – 2019-12-31
−USD 21.37 million
Exact value

Exact value: -21373000 USD

2019-01-01 – 2019-12-31: -21373000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.1 million
Exact value

Exact value: -8102000 USD

2019-01-01 – 2019-12-31: -8102000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 408,000
Exact value

Exact value: 408000 USD

2019-01-01 – 2019-12-31: 408000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.51 million
Calculation and evidence

-8102000 − 408000 USD

Exact free cash flow: -8510000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 30.62 million
Exact value

Exact value: -30621000 USD

2020-01-01 – 2020-12-31: -30621000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.72 million
Exact value

Exact value: -9722000 USD

2020-01-01 – 2020-12-31: -9722000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 673,000
Exact value

Exact value: 673000 USD

2020-01-01 – 2020-12-31: 673000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.4 million
Calculation and evidence

-9722000 − 673000 USD

Exact free cash flow: -10395000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 13.19 million
Exact value

Exact value: -13193000 USD

2021-01-01 – 2021-12-31: -13193000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.32 million
Exact value

Exact value: -4315000 USD

2021-01-01 – 2021-12-31: -4315000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.32 million
Calculation and evidence

-4315000 − 0 USD

Exact free cash flow: -4315000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 25.51 million
Exact value

Exact value: -25509000 USD

2022-01-01 – 2022-12-31: -25509000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.07 million
Exact value

Exact value: -10073000 USD

2022-01-01 – 2022-12-31: -10073000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1,000
Exact value

Exact value: 1000 USD

2022-01-01 – 2022-12-31: 1000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.07 million
Calculation and evidence

-10073000 − 1000 USD

Exact free cash flow: -10074000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 3.44 million
Exact value

Exact value: -3444000 USD

2023-01-01 – 2023-12-31: -3444000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.84 million
Exact value

Exact value: -3843000 USD

2023-01-01 – 2023-12-31: -3843000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2,000
Exact value

Exact value: 2000 USD

2023-01-01 – 2023-12-31: 2000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.85 million
Calculation and evidence

-3843000 − 2000 USD

Exact free cash flow: -3845000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 2,810 latest values · 2,810 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001643301, 1643301, AVRW, CURR, edgar:1643301, mknn, mknt

Also known as AVENIR WELLNESS SOLUTIONS, INC., Avenir Wellness Solutions, Inc., CURE PHARMACEUTICAL HOLDING CORP, CURE PHARMACEUTICAL HOLDING CORP., Cure Pharmaceutical Holding Corp., Makkanotti Group Corp.